{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:17:06Z","timestamp":1778044626610,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12753-2","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:52:47Z","timestamp":1745207567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors associated with pain episodes among sickle cell patients that visited Mulago National Referral Hospital-Uganda"],"prefix":"10.1186","volume":"25","author":[{"given":"Nassiwa","family":"Shamira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asiimwe John","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nsimbe","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4454-1795","authenticated-orcid":false,"given":"Charles","family":"Lwanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"12753_CR1","doi-asserted-by":"publisher","unstructured":"Herrick J.B. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med. 1910;VI5:517\u201321. https:\/\/doi.org\/10.1001\/archinte.1910.00050330050003.","DOI":"10.1001\/archinte.1910.00050330050003"},{"key":"12753_CR2","unstructured":"CDC. What Is Sickle Cell Disease? National Center on Births Defects and Developmental Disabilities, Center for Disease Control and Prevention. 2020;4."},{"key":"12753_CR3","doi-asserted-by":"publisher","unstructured":"Inusa BPD, et al. Sickle cell disease\u2014genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen (Vol. 2019;5(2). https:\/\/doi.org\/10.3390\/ijns5020020.","DOI":"10.3390\/ijns5020020"},{"key":"12753_CR4","doi-asserted-by":"publisher","unstructured":"Ndila C et al. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study. Lancet Haematol. 2018;5(8):e333- e345. https:\/\/doi.org\/10.1016\/S2352-3026(18)30107-8. Epub 2018 Jul 20. PMID: 30033078; PMCID: PMC6069675. 2018.","DOI":"10.1016\/S2352-3026(18)30107-8"},{"key":"12753_CR5","doi-asserted-by":"publisher","unstructured":"Editorial. Sickle cell trait. Bri Med J. 1976;1(6022):1359\u20131360. https:\/\/doi.org\/10.1136\/bmj.1.6022.1359.","DOI":"10.1136\/bmj.1.6022.1359"},{"issue":"49","key":"12753_CR6","first-page":"1155","volume":"63","author":"J Ojodu","year":"2014","unstructured":"Ojodu J, et al. Incidence of sickle cell trait\u2013United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(49):1155\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"12753_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3949\/CCJM.87A.18051","volume":"87","author":"G Onimoe","year":"2020","unstructured":"Onimoe G. S. Rotz 2020 Sickle cell disease: A primary care update. Cleve Clin J Med 87 1 19\u201327 https:\/\/doi.org\/10.3949\/CCJM.87A.18051.","journal-title":"Cleve Clin J Med"},{"key":"12753_CR8","unstructured":"Excelence N.I.C. Sickle cell acute painful episode. Sickle cell acute painful episode: Manage Acute Painful Sickle Cell Episode Hosp. 2012;143(June):1\u2013179. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK126761\/."},{"key":"12753_CR9","doi-asserted-by":"crossref","unstructured":"Treede RD, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain. 2019;160(1):19\u201327.","DOI":"10.1097\/j.pain.0000000000001384"},{"key":"12753_CR10","unstructured":"WHO. Sickle cell disease prevention and control - WHO| Regional Office for Africa. 2015. https:\/\/www.afro.who.int\/health-topics\/sickle-cell-disease."},{"key":"12753_CR11","unstructured":"WHO. F. and n.w.H. A, Sickle-Cell Anaemia Report by the Secretariat.\\n. In Fifty-ninth World Health Assembly. 2006. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA59\/A59_9-en.pdf."},{"key":"12753_CR12","doi-asserted-by":"publisher","unstructured":"Piel F.B., et al. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7). https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1001484.","DOI":"10.1371\/JOURNAL.PMED.1001484"},{"key":"12753_CR13","doi-asserted-by":"publisher","unstructured":"Ndeezi G, et al. Burden of sickle cell trait and disease in the Uganda sickle surveillance study (US3): a cross-sectional study. Lancet Global Health. 2016;4(3):e195\u20137. https:\/\/doi.org\/10.1016\/S2214-109X(15)00288-0.","DOI":"10.1016\/S2214-109X(15)00288-0"},{"key":"12753_CR14","unstructured":"Lancet Haematol. 2022;9(3):e208\u201316."},{"key":"12753_CR15","unstructured":"World Health Organization. WHO Sickle Cell Disease Package of Interventions. Geneva: World Health Organization. 2024. Available from: https:\/\/www.afro.who.int\/health-topics\/sickle-cell-disease."},{"key":"12753_CR16","unstructured":"UBOS, Uganda demographic and health survey 2016. Udhs, 625. Www.DHSprogram.comUBOS. Uganda Demographic Health Surv 2016 Udhs, 625. www.DHSprogram.com. 2016.\u00a02016.\u00a0"},{"key":"12753_CR17","unstructured":"MOH. Press statement ahead of World Sickle Cell Day. 2017. https:\/\/www.health.go.ug\/document\/press-statement-ahead-of-world-sickle-cell-day\/."},{"key":"12753_CR18","unstructured":"MOH, Uganda: Sickle Cells Disease On the Rise in Uganda| Knowledge Management Portal. In Knowledge Management Portal. 2013, p. 1. http:\/\/library.health.go.ug\/news\/uganda-sickle-cells-disease-rise-uganda.\u00a0"},{"key":"12753_CR19","doi-asserted-by":"publisher","unstructured":"Inusa BPD et al. Sickle cell disease\u2014genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019;5(2):1\u20132. International Journal of Neonatal Screening. https:\/\/doi.org\/10.3390\/ijns5020020.\u00a0","DOI":"10.3390\/ijns5020020"},{"issue":"6","key":"12753_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.blre.2013.09.001","volume":"27","author":"J Kanter","year":"2013","unstructured":"Kanter J, Kruse-Jarres R. Management of sickle cell disease from childhood through adulthood. Blood Rev. 2013;27(6):279\u201387. https:\/\/doi.org\/10.1016\/j.blre.2013.09.001.","journal-title":"Blood Rev"},{"key":"12753_CR21","doi-asserted-by":"crossref","unstructured":"Gillis VL. Management of an acute painful sickle cell episode in hospital: Summary of NICE guidance. BMJ (Online). 2012;345(7866):1. https:\/\/doi.org\/10.1136\/bmj.e4063 Gould, W., & Pitblado, W. (2010). stata.com.\u00a0","DOI":"10.1136\/bmj.e4063"},{"key":"12753_CR22","unstructured":"Staff MC. Sickle cell anemia - Symptoms and causes - Mayo Clinic. In Mayo Clinic. 2020.\u00a0https:\/\/www.mayoclinic.org\/diseases-conditions\/sickle-cell-anemia\/symptoms-causes\/syc-20355876."},{"key":"12753_CR23","unstructured":"SCA news. Pain management guidelines for sickle cell disease. Pain Management Guidelines for Sicke Cell Disease. 2022. https:\/\/sicklecellanemianews.com\/pain-management-guidelines-for-sickle-cell-anemia\/."},{"key":"12753_CR24","doi-asserted-by":"publisher","unstructured":"Tusuubira SK et al. Knowledge, perception and practices towards sickle cell disease: A community survey among adults in Lubaga division, Kampala Uganda. BMC Public Health. 2018;18(1):561. https:\/\/doi.org\/10.1186\/s12889-018-5496-4.","DOI":"10.1186\/s12889-018-5496-4"},{"key":"12753_CR25","unstructured":"Modenesi B. Poisson distribution. In Wikipedia.\u00a02021. https:\/\/en.wikipedia.org\/wiki\/Poisson_distribution."},{"key":"12753_CR26","doi-asserted-by":"publisher","unstructured":"Ulrich Kohler FK. Journal of statistical software. In Data Analysis Using Stata, 3rd Edition: revised. Taylor & Francis; 2012. Vols. 3. 2012.\u00a0\u00a0https:\/\/doi.org\/10.1002\/wics.10.\u00a0","DOI":"10.1002\/wics.10"},{"key":"12753_CR27","unstructured":"Gould W, Pitblado J, Poi B. Maximum Likelihood Estimation with Stata. 4th ed. College Station: Stata Press; 2010."},{"key":"12753_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ajh.20075","volume":"76","author":"TDH Mckerrell","year":"2004","unstructured":"Mckerrell TDH, Cohen HW, Billett HH. The older sickle cell patient. J Hematol. 2004;76:101\u20136. https:\/\/doi.org\/10.1002\/ajh.20075.","journal-title":"J Hematol"},{"key":"12753_CR29","doi-asserted-by":"crossref","unstructured":"Brandow MA, Zappia JK, Stucky LC. Sickle cell disease: a natural model of acute and chronic pain. PMC, 2017: pp. 79\u201384.","DOI":"10.1097\/j.pain.0000000000000824"},{"key":"12753_CR30","first-page":"182","volume-title":"Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease","author":"AJ Panepinto","year":"2004","unstructured":"Panepinto AJ, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Wiley Online Library; 2004. pp. 182\u20136."},{"key":"12753_CR31","doi-asserted-by":"publisher","unstructured":"Idris, I.M., E.A. Botchwey, and H.I. Hyacinth, Sickle cell disease as an accelerated aging syndrome. Exp Biol Med (Maywood, N.J.). 2022;247(4):368\u201374. https:\/\/doi.org\/10.1177\/15353702211068522.","DOI":"10.1177\/15353702211068522"},{"issue":"5","key":"12753_CR32","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1097\/PR9.0000000000001084","volume":"8","author":"RL Astles","year":"2023","unstructured":"Astles RL, Gillespie Z, Lai SE, Maillis KW, Morris A, Bakshi CR. Sex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease. Pain Rep. 2023;8(5):e1084.","journal-title":"Pain Rep"},{"key":"12753_CR33","unstructured":"Smith RW et al. The association between hydroxyurea treatment and pain intensity, analgesic use, and utilisation in ambulatory sickle cell anaemia patients. NLH. 2011: pp. 3\u20134."},{"key":"12753_CR34","unstructured":"Maakaron EJ, Taher TA. What are the effects of hydroxyurea in patients with sickle cell disease (SCD), in Medscape. 2020."},{"key":"12753_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12936-020-03212-w","volume":"19","author":"RO Mwaiswelo","year":"2020","unstructured":"Mwaiswelo RO, Mawala W, Iversen PO, et al. Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum. Malar J. 2020;19:165. https:\/\/doi.org\/10.1186\/s12936-020-03212-w.","journal-title":"Malar J"},{"issue":"3","key":"12753_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.54293\/smhj.v3i3.82","volume":"3","author":"H Osman Mirghani","year":"2023","unstructured":"Osman Mirghani H, et al. Association between sickle cell Anemia and malaria: A systematic review of previous literature: sickle cell Anemia and malaria: A systematic review. Saudi Med Horizons J. 2023;3(3):118\u201330. https:\/\/doi.org\/10.54293\/smhj.v3i3.82.","journal-title":"Saudi Med Horizons J"},{"key":"12753_CR37","doi-asserted-by":"publisher","unstructured":"Luzzatto L. Sickle cell anaemia and malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012065. https:\/\/doi.org\/10.4084\/MJHID.2012.065.","DOI":"10.4084\/MJHID.2012.065"},{"key":"12753_CR38","unstructured":"Complications and treatments of sickle cell disease. Centers Disease Control Prev. 2020:1\u20136."},{"key":"12753_CR39","unstructured":"Rogers ZR. UpToDate, in Management of fever in sickle cell disease. 2020."},{"key":"12753_CR40","unstructured":"St. Jude Children's Research Hospital. Infection and sickle cell disease. 2021. https:\/\/together.stjude.org\/en-us\/treatment-tests-procedures\/symptoms-side-effects\/infection-and-sickle-cell-disease.html."},{"key":"12753_CR41","doi-asserted-by":"publisher","unstructured":"Dei-Adomakoh YA et al. Hydroxyurea for Children and Adults with Hemoglobin SC Disease. NEJM Evid. 2025;4(2):EVIDoa2400402. https:\/\/doi.org\/10.1056\/EVIDoa2400402. Epub 2024 Dec 8. PMID: 39647172.","DOI":"10.1056\/EVIDoa2400402"},{"key":"12753_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1813598","volume":"380","author":"L Tshilolo","year":"2019","unstructured":"Tshilolo L, Tomlinson G, Williams TN, et al. Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. N Engl J Med. 2019;380:121\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1813598.","journal-title":"N Engl J Med"},{"key":"12753_CR43","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1016\/S2352-3026(24)00078-4","volume":"11","author":"B Aygun","year":"2024","unstructured":"Aygun B, Lane A, Smart LR, et al. Hydroxyurea dose optimisation for children with sickle cell anemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1\/2 trial. Lancet Haematol. 2024;11:e425\u201335. https:\/\/doi.org\/10.1016\/S2352-3026(24)00078-4.","journal-title":"Lancet Haematol"},{"key":"12753_CR44","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","volume":"130","author":"RO Opoka","year":"2017","unstructured":"Opoka RO, Ndugwa CM, Latham TS, et al. Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia. Blood. 2017;130:2585\u201393. https:\/\/doi.org\/10.1182\/blood-2017-06-788935.","journal-title":"Blood"},{"key":"12753_CR45","unstructured":"Houchens R. Missing Data Methods for the NIS and the SID. Agency for Healthcare Research and Quality No. 2015\u201301. HCUP Methods Series Report. 2015. https:\/\/www.hcupus.ahrq.gov\/reports\/methods\/2015_01.pdf."},{"issue":"3","key":"12753_CR46","first-page":"79","volume":"4","author":"MR Abonazel","year":"2018","unstructured":"Abonazel MR, Ibrahim MG. On Estimation methods for binary logistic regression model with missing values. Int J Math Comput Sci. 2018;4(3):79\u201385.","journal-title":"Int J Math Comput Sci"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12753-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:53:09Z","timestamp":1745207589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12753-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12753"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12753-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Utilizing secondary data with person from Mulago referral hospital, the study was approved by the Mulago hospital research and ethics committee during the original survey. Moreover, informed consent was obtained from all participants or their legal guardian(s) as part of the data collection process. The study adheres to the ethical and consent procedures. All procedures contributing to this research adhered to the ethical standards set by relevant national and institutional committees for human experimentation, as well as the Helsinki Declaration of 1975, amended in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}